Mauritius-based Caduceus Asia Mauritius Ltd to pick up 11.93% stake in Shasun Pharmaceuticals Ltd, by infusing Rs 50 crore. The promoters’ holding will come down to 41.15% from the current 46.73%. The money will be used to pay long term funds for the company and to part finance the capex, according to the company. Caduceus Asia Mauritius Ltd is a part of OrbiMed, a private equity fund focusing on healthcare. OrbiMed has earlier invested in Clinical Research firm Ecron Acunova […]